Edition:
United Kingdom

People: Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

19.50EUR
15 Aug 2019
Change (% chg)

-- (--)
Prev Close
€19.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,007
52-wk High
€28.90
52-wk Low
€18.00

Mack, Michael 

Dr. Michael Mack has been Independent Director of Carmat SA since January 2, 2017. He is an internationally renowned cardiac surgeon with extensive experience in the introduction of medical devices and innovative procedures for cardiovascular disease. He has authored more than 650 scientific publications and has received the Presidential Citation from the American College of Cardiology (ACC) and the Transcatheter Cardiovascular Therapeutics (TCT) Lifetime Achievement Award. Dr Mack is a graduate of Boston College, St Louis University and the University of Texas Southwestern Medical School. He is also the Director of the Cardiovascular department for pharmaceutical firm Baylor Scott & White Health, a Director on the American Board of Thoracic Surgery and a member of the FDA Medical Device Epidemiology Network Initiative (MDEpiNet) Advisory Committee.

Basic Compensation

Total Annual Compensation, EUR 28,390
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 28,390

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --